222 related articles for article (PubMed ID: 15647195)
1. Effect of central corticotropin releasing factor on hepatic circulation in rats: the role of the CRF2 receptor in the brain.
Yoneda M; Nakamura K; Nakade Y; Tamano M; Kono T; Watanobe H; Shimada T; Hiraishi H; Terano A
Gut; 2005 Feb; 54(2):282-8. PubMed ID: 15647195
[TBL] [Abstract][Full Text] [Related]
2. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats.
Czimmer J; Million M; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G511-8. PubMed ID: 16223946
[TBL] [Abstract][Full Text] [Related]
3. Effect of central corticotropin-releasing factor on carbon tetrachloride-induced acute liver injury in rats.
Yokohama S; Yoneda M; Nakamura K; Makino I
Am J Physiol; 1999 Mar; 276(3):G622-8. PubMed ID: 10070038
[TBL] [Abstract][Full Text] [Related]
4. Involvement of endogenous CRF in carbon tetrachloride-induced acute liver injury in rats.
Nakade Y; Yoneda M; Nakamura K; Makino I; Terano A
Am J Physiol Regul Integr Comp Physiol; 2002 Jun; 282(6):R1782-8. PubMed ID: 12010761
[TBL] [Abstract][Full Text] [Related]
5. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
[TBL] [Abstract][Full Text] [Related]
6. Intracisternal urocortin inhibits vagally stimulated gastric motility in rats: role of CRF(2).
Chen CY; Million M; Adelson DW; Martínez V; Rivier J; Taché Y
Br J Pharmacol; 2002 May; 136(2):237-47. PubMed ID: 12010772
[TBL] [Abstract][Full Text] [Related]
7. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
9. Effect of central thyrotropin-releasing hormone on pancreatic blood flow in rats.
Goto M; Yoneda M; Nakamura K; Terano A; Haneda M
Regul Pept; 2004 Sep; 121(1-3):57-63. PubMed ID: 15256274
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
Stiedl O; Meyer M; Jahn O; Ogren SO; Spiess J
J Pharmacol Exp Ther; 2005 Mar; 312(3):905-16. PubMed ID: 15537825
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin-releasing hormone in the dorsal vagal complex stimulates hepatic blood flow in rats.
Yoneda M; Hashimoto T; Nakamura K; Tamori K; Yokohama S; Kono T; Watanobe H; Terano A
Hepatology; 2003 Dec; 38(6):1500-7. PubMed ID: 14647061
[TBL] [Abstract][Full Text] [Related]
12. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
[TBL] [Abstract][Full Text] [Related]
13. Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats.
Nakade Y; Tsukamoto K; Pappas TN; Takahashi T
Brain Res; 2006 Sep; 1111(1):117-21. PubMed ID: 16884700
[TBL] [Abstract][Full Text] [Related]
14. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
15. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
[TBL] [Abstract][Full Text] [Related]
17. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
Oliveira LA; Almeida J; Benini R; Crestani CC
Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
[TBL] [Abstract][Full Text] [Related]
18. Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat.
Inoue K; Valdez GR; Reyes TM; Reinhardt LE; Tabarin A; Rivier J; Vale WW; Sawchenko PE; Koob GF; Zorrilla EP
J Pharmacol Exp Ther; 2003 Apr; 305(1):385-93. PubMed ID: 12649393
[TBL] [Abstract][Full Text] [Related]
19. Central thyrotropin-releasing hormone increases hepatic cyclic AMP through vagal-cholinergic and prostaglandin-dependent pathways in rats.
Yoneda M; Kono T; Watanobe H; Tamano M; Shimada T; Hiraishi H; Nakamura K
Peptides; 2005 Sep; 26(9):1573-9. PubMed ID: 16112395
[TBL] [Abstract][Full Text] [Related]
20. Influence of urocortin and corticotropin releasing factor on venous tone in conscious rats.
Abdelrahman AM; Lin Lim S; Pang CC
Eur J Pharmacol; 2005 Mar; 510(1-2):107-11. PubMed ID: 15740730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
